A clinical study of SP-26 for chronic pain and mental health indications
Latest Information Update: 08 May 2025
At a glance
- Drugs Ketamine (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions
Most Recent Events
- 08 May 2025 New trial record
- 30 Apr 2025 According to a Silo Pharma media release, company to advance SP-26 , toward clinical studies. If clinically successful, SP-26 could qualify for the FDA's streamlined 505(b)(2) regulatory pathway for drug approval.